Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services

A Contract Award Notice
by NHS SUPPLY CHAIN ACTING AS AGENT FOR SUPPLY CHAIN COORDINATION LTD

Source
OJEU
Type
Framework (Supply)
Duration
4 year (est.)
Value
€20B
Sector
HEALTH
Published
02 Nov 2020
Delivery
To 02 Nov 2024 (est.)
Deadline
n/a

Concepts

Location

Warrington

Geochart for 2 buyers and 3 suppliers

2 buyers

3 suppliers

Description

NHS Supply Chain seeks to establish a non-exclusive framework agreement for the supply to the NHS Supply Chain customer base via the E-Direct/Direct Route of pathology and point of care testing, associated equipment, instruments, consumables, accessories and managed services. This framework will include 2 lots: Lot 1: Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables, Accessories(Capital, Reagent, Reagent Rental and Primary Contractor Managed Services. Lot 2: Managed Services Category.

Lot Division

1 Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables, Accessories (Capital, Reagent, Reagent Rental and Primary Contractor Managed Services)
2 Managed Services

Lot 1: Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables, Accessories (Capital, Reagent, Reagent Rental and Primary Contractor Managed Services); Lot 2: Managed Services Category (Primary Contractor refer to 18. List of Definitions and Interpretations).

Award Detail

1 Ab Scientific (Sutton in Ashfield)
  • Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services
2 Pisces Scientific (Dundee)
  • Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services
3 Abbott Laboratories (Maidenhead)
  • Managed Services

CPV Codes

  • 33100000 - Medical equipments
  • 33124130 - Diagnostic supplies
  • 51410000 - Installation services of medical equipment
  • 72212180 - Medical software development services
  • 85148000 - Medical analysis services
  • 85150000 - Medical imaging services

Indicators

  • Options are not available.

Other Information

Increase Value to GBP 20 bn While there is no commitment to any value of spend on a framework agreement it has become apparent since contract notice publication that spend is likely to exceed the estimated framework value stated in the contract notice. This is mainly due to the pandemic situation resulting in an immediate overall increased spend in support of Covid-19 testing programme. Future value of spend and procurement route for this programme over the term of the framework agreement cannot be accurately forecast at the time of award publication and the revised value published includes a high-end estimate of this value. In addition, there are further impacts of Covid-19 on the pathology and diagnostics market which may result in an overall increase in spend in the market as demand for services increases. This impact cannot be accurately forecast at the time of award and the revised value published included a high-end estimate of this value. The revised value represents the total value of contracts that could be awarded under the framework during its term and takes into account that these contracts are likely to be multi-year.

Reference

Domains